Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists-Reference-Cited by-同舟云学术

Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists

Published:2016-11-18 Issue:2 Volume:91 Page:87-99
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Riddy Darren M.,Cook Anna E.,Diepenhorst Natalie A.,Bosnyak Sanja,Brady Ryan,Mannoury la Cour Clotilde,Mocaer Elisabeth,Summers Roger J.,Charman William N.,Sexton Patrick M.,Christopoulos Arthur,Langmead Christopher J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference58 articles.

1. Constitutive activity of the histamine H3 receptor

2. Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

3. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist

4. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways

5. Histamine H3 Receptor as a Drug Discovery Target

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

2. Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity;Biomolecules;2024-06-26

3. Pharmacological characterization of seven human histamine H3 receptor isoforms;European Journal of Pharmacology;2024-04

4. Pharmacological characterization of seven human histamine H₃receptor isoforms;2023-12-11

5. Ligand-directed biased agonism at human histamine H3 receptor isoforms across Gαi/o- and β-arrestin2-mediated pathways;Biochemical Pharmacology;2023-12